IDEX Corporation Reports Strong Q2 Performance with Organic Growth and Strategic Shifts
In its second-quarter earnings call, IDEX Corporation reported organic growth of 5% driven by strategic pivots toward data centers, semiconductors, space, and defense markets. The Health & Science Technologies segment led the performance with a remarkable 47% increase in orders due to demand for liquid cooling infrastructure linked to rapid data center expansion. The company's semiconductor portfolio has transitioned to a more resilient model, now generating approximately 50% recurring revenue post-Mott acquisition. In Fluid & Metering Technologies, double-digit growth was driven by municipal wastewater analytics and high-purity solutions for semiconductors. Management noted improved visibility into long-term demand from large OEM commitments extending through 2027. IDEX raised its full-year organic growth guidance to 5-6%, citing a strong order book in HST and signs of recovery in industrial markets. Capital expenditures are expected to reach $110 million for capacity expansion, with continued volume leverage anticipated into the second half.
Topics: capital expenditure earnings organic growth segment performance